(Press-News.org) An analysis of previous studies indicates that compared with chemotherapy alone, use of the cancer drug bevacizumab in combination with chemotherapy or biological therapy is associated with an increased risk of treatment-related death, according to an article in the February 2 issue of JAMA.
A fatal adverse event (FAE) is defined as a death caused in all likelihood by a drug and is a major cause of fatality in the United States. Bevacizumab was approved in combination with chemotherapy for treating many types of advanced cancer, including colorectal cancer, non-small cell lung cancer, breast cancer, and renal cell carcinoma. "Even though a number of FAEs have been reported in patients treated with bevacizumab, its role in the development of these fatal events has not been definitively established. Data across bevacizumab trials reveal conflicting results regarding its associations with FAEs," according to background information in the article.
Vishal Ranpura, M.D., of Stony Brook University Medical Center, Stony Brook, N.Y., and colleagues conducted a review and meta-analysis of published randomized controlled trials (RCTs) to determine whether bevacizumab is associated with increased rates of FAEs in patients with cancer. The researchers identified and included 16 RCTs in the analysis. These RCTs included a total of 10,217 patients with a variety of advanced solid tumors. Eligible studies included RCTs in which bevacizumab in combination with chemotherapy or biological therapy was compared with chemotherapy or biological therapy alone.
The overall incidence of FAEs with bevacizumab was 2.5 percent. Compared with chemotherapy alone, the addition of bevacizumab was associated with a 1.5 times increased risk of FAEs. This association varied significantly with chemotherapeutic agents but not with tumor types or bevacizumab doses. Bevacizumab was associated with a 3.5 times increased risk of FAEs in patients receiving taxanes or platinum agents (3.3 percent vs. 1.0 percent), but was not associated with increased risk of FAEs when used in conjunction with other agents.
Common specific causes of FAEs included hemorrhage (23.5 percent), neutropenia (a blood disorder; 12.2 percent), gastrointestinal tract perforation (7.1 percent), pulmonary embolism (5.1 percent), and cerebrovascular accident (5.1 percent). Pulmonary (14/23) and gastrointestinal hemorrhage (6/23) accounted for most fatal bleeding events.
The authors write that given the absolute risk of treatment-related mortality appears low, the use of bevacizumab should be considered in the context of overall survival benefits. They add that because bevacizumab is increasingly used in cancer patients, it is particularly important for all health care practitioners and patients to understand and recognize the risk of treatment-related mortality and to monitor closely to identify and treat serious adverse effects.
(JAMA. 2011;305[5]:487-494. Available pre-embargo to the media at www.jamamedia.org)
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Editorial: Bevacizumab Treatment for Solid Tumors
In an accompanying editorial, Daniel F. Hayes, M.D., of the University of Michigan Comprehensive Cancer Center, Ann Arbor, Mich., writes that careful review of response rates to bevacizumab suggest that bevacizumab works well, but only in selected patients.
"Is bevacizumab a boon or a bust? The jury is still out. Although bevacizumab has benefit, it is currently not possible to determine in whom or for how long. Thus, oncologists are forced to dilute the potential effects of bevacizumab by exposing all treated patients, and society, to enormous costs and occasional life-threatening toxic effects. These unfortunate circumstances are sad for those who pay the bills— and sadder for patients with solid tumors."
INFORMATION:
(JAMA. 2011;305[5]:506-508. Available pre-embargo to the media at www.jamamedia.org)
Editor's Note: Please see the article for additional information, including financial disclosures, funding and support, etc.
To contact corresponding author Shenhong Wu, M.D., Ph.D., call Greg Filiano at 631-444-9343 or email gfiliano@notes.cc.sunysb.edu. To contact editorial author Daniel F. Hayes, M.D., call Nicole Fawcett at 734-764-2220 or email nfawcett@med.umich.edu.
For More Information: Contact the JAMA/Archives Media Relations Department at 312-464-JAMA or email: mediarelations@jama-archives.org.
Cancer drug used in combination with other therapies associated with increased risk of death
2011-02-02
ELSE PRESS RELEASES FROM THIS DATE:
Wide variation exists in receipt of recommended medications for Medicare managed care RA patients
2011-02-02
An analysis of data from more than 90,000 Medicare managed care enrollees who received care for rheumatoid arthritis finds that more than one-third did not receive the recommended treatment with a disease-modifying antirheumatic drug, and that receipt varied by demographic factors, socioeconomic status, geographic location and health plan, according to a study in the February 2 issue of JAMA.
Despite evidence-based guidelines recommending early and aggressive treatment of active rheumatoid arthritis (RA), recent population-based studies of disease-modifying antirheumatic ...
In tiny fruit flies, researchers identify metabolic 'switch' that links normal growth to cancer
2011-02-02
SALT LAKE CITY—As day-old embryos, fruit flies called Drosophila enter a stage in which their cells freely divide and proliferate as the insect grows dramatically in size.
This is true for all animals, which undergo most of their growth prior to sexual maturation. Until now, researchers have known nothing about the metabolic state that occurs when cells divide during early development. But in a study published online Tuesday, Feb. 1, 2011, in Cell Metabolism, University of Utah human genetics researchers show that this cell division in Drosophila depends on a metabolic ...
New tumor-tracking technique for radiotherapy spares healthy tissue, could improve cancer treatment
2011-02-02
PHILADELPHIA—Medical physicists at Thomas Jefferson University and Jefferson's Kimmel Cancer Center have demonstrated a new real-time tumor tracking technique that can help minimize the amount of radiation delivered to surrounding healthy tissue in a patient—up to 50 percent less in some cases—and maximize the dose the tumor receives.
Respiratory and cardiac motions have been found to displace and deform tumors in the lung, pancreas, liver, breast, and other organs. Because of this, radiation oncologists must expand the margin during radiotherapy. Consequently, a large ...
BIDMC researchers conclude nonprofit hospices disproportionately care for costly patients
2011-02-02
BOSTON – For-profit hospice agencies had a higher percentage of patients with diagnoses associated with less skilled care and longer lengths of stay (LOS) in hospice, than their nonprofit counterparts, a difference that may leave "nonprofit hospice agencies disproportionately caring for the most costly patients," Beth Israel Deaconess Medical Center researchers report.
The findings appear in the Feb.2 issue of the Journal of the American Medical Association (JAMA).
"There was a big increase in the number of for-profit hospice agencies from 2000 to 2007, and previous ...
Internet addresses: An inevitable shortage, but an uneven one
2011-02-02
As Internet authorities prepare to announce that they have handed over all of the available addresses, a USC research group that monitors address usage has completed the latest in its series of Internet censuses.
There is some good news, according to computer scientist John Heideman, who heads a team at the USC Viterbi School of Engineering Information Sciences Institute that has just released its results in the form of a detailed outline, including a 10-minute video and an interactive web browser that allows users to explore the nooks and crannies of Internet space themselves.
video: ...
New quartet of ant genomes advanced by international collaborative
2011-02-02
"Look to the ant thou sluggard and consider her ways and be wise." This proverbial wisdom was taken to heart recently by an international group of ant experts who have published the genome sequences of four ants in a series of coordinated releases in the journal Proceedings of the National Academy of Sciences (PNAS). The quartet includes the genomes of the red harvester ant Pogonomyrmex barbatus; the Argentine ant Linepithema humile; the fire ant Solenopsis invicta, and the leaf-cutter ant Atta cephalotes, whose genome will be published on Feb. 10 in Public Library of Science ...
Go green, give a boost to employee morale
2011-02-02
In a global recession, most people are thankful to have a job, but a new study published in Interdisciplinary Environmental Review suggests that employees are more likely to be satisfied with their jobs if they are working for a company that is perceived to be "green", whereas the financial performance of companies fails to correlate with employee happiness.
Cassandra Walsh and Adam Sulkowski, both of the Charlton College of Business at University of Massachusetts Dartmouth, wanted to know whether employee morale is typically affected when a company is perceived as taking ...
New test to study proteins involved in neurodegenerative diseases
2011-02-02
Researchers from the Institute of Biotechnology and Biomedicine and the UAB Department of Biochemistry and Molecular Biology have developed and patented a method using Saccharomyces cerevisiae yeast to detect in human proteins the formation of oligomers, small toxic aggregations of molecules which can initiate the assembly of amyloid fibres found in neurodegenerative diseases. The test allows validating the efficacy of compounds which could dissolve or inhibit these aggregates, as well as studying at basic level the therapeutic potentiality of a large number of molecules. ...
Home and away: How do invasive plant species dominate native species?
2011-02-02
Invasive plant species present a serious environmental, economic and social problem worldwide as their abundance can lead to lost native biodiversity and ecosystem functions, such as nutrient cycling. Despite substantial research, little is known about why some species can dominate new habitats over native plants that technically should have the advantage.
A common but rarely tested assumption is that these plants are more abundant in introduced versus native communities, because they are behaving in special way. If this true and introduced species are behaving in a special ...
Protracted abstinence revisited
2011-02-02
Philadelphia, PA, 1 February 2011 - Opiate abuse is a chronic disorder and maintaining abstinence represents a major challenge for addicts.
Individuals recovering from opiate dependence have long reported that while the acute withdrawal symptoms from opiates may pass relatively quickly, they do not feel quite right for several weeks or even months thereafter. Called the "protracted abstinence syndrome," this cluster of vague depressive-like symptoms can include reduced concentration, low energy level, poor sleep quality, and anhedonia.
New data in animals, reported ...